These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19603122)

  • 1. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.
    Yin P; Wan D; Zhao C; Chen J; Zhao X; Wang W; Lu X; Yang S; Gu J; Xu G
    Mol Biosyst; 2009 Aug; 5(8):868-76. PubMed ID: 19603122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.
    Lian JS; Liu W; Hao SR; Guo YZ; Huang HJ; Chen DY; Xie Q; Pan XP; Xu W; Yuan WX; Li LJ; Huang JR
    Chin Med J (Engl); 2011 May; 124(9):1367-73. PubMed ID: 21740750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
    Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.
    Li S; Liu H; Jin Y; Lin S; Cai Z; Jiang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2369-75. PubMed ID: 21763219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus.
    Zhang L; Jia X; Peng X; Ou Q; Zhang Z; Qiu C; Yao Y; Shen F; Yang H; Ma F; Wang J; Yuan Z
    Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):688-98. PubMed ID: 20810534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
    Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
    J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies.
    Spagou K; Tsoukali H; Raikos N; Gika H; Wilson ID; Theodoridis G
    J Sep Sci; 2010 Mar; 33(6-7):716-27. PubMed ID: 20187037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of acetylcholine, choline and butyrobetaine in human liver tissues by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Wang Y; Wang T; Shi X; Wan D; Zhang P; He X; Gao P; Yang S; Gu J; Xu G
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):870-5. PubMed ID: 18407448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Huang G; Xie S; Wang M; Mao D; Huang G; Huang J; Liu X; Zhang R; Xie J; Huang LJ; Cheng C; Yao F; Zhong Y; Lin L; Yao C
    Biomed Chromatogr; 2023 Jan; 37(1):e5529. PubMed ID: 36250932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures.
    Croixmarie V; Umbdenstock T; Cloarec O; Moreau A; Pascussi JM; Boursier-Neyret C; Walther B
    Anal Chem; 2009 Aug; 81(15):6061-9. PubMed ID: 19588937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent cirrhosis in hepatitis B virus related hepatocellular carcinoma.
    Singal AK
    Hepatogastroenterology; 2008; 55(86-87):1734-7. PubMed ID: 19102380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS).
    Yin P; Zhao X; Li Q; Wang J; Li J; Xu G
    J Proteome Res; 2006 Sep; 5(9):2135-43. PubMed ID: 16944924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS.
    Chen S; Yin P; Zhao X; Xing W; Hu C; Zhou L; Xu G
    Electrophoresis; 2013 Oct; 34(19):2848-56. PubMed ID: 24228263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations.
    García-Cañaveras JC; Donato MT; Castell JV; Lahoz A
    J Proteome Res; 2011 Oct; 10(10):4825-34. PubMed ID: 21830829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
    Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry.
    Cai X; Zou L; Dong J; Zhao L; Wang Y; Xu Q; Xue X; Zhang X; Liang X
    Anal Chim Acta; 2009 Sep; 650(1):10-5. PubMed ID: 19720166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.